Supplier of Pediatric and Low-Dose Formulations

This contract involves the supply of low-dose medications formulated in precise strengths specifically designed for pediatric or sensitive-dose research studies. It is a subcontract opportunity issued by the FDA Office of Acquisition and Grant Services, under the Department of Health and Human Services, aimed at sourcing specialized pharmaceutical formulations that meet the stringent requirements of pediatric research. The contract pertains to NAICS code 325412, which relates to pharmaceutical preparation manufacturing. The solicitation was posted on May 4, 2026, and the response deadline is May 15, 2026. While specific details such as location, point of contact, and set-aside status are not provided, the focus is clearly on providing tailored low-dose drug products suitable for research environments requiring exact dosing for vulnerable populations. The contractor will play a vital role in supporting health research by ensuring that these medications are available with the necessary accuracy and quality standards.